Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men

Ex vivo studies have shown that the gastrin releasing peptide receptor (GRPr) is overexpressed on almost all primary prostate cancers, making it a promising target for prostate cancer imaging and targeted radiotherapy. Methods: Biodistribution, dosimetry and tumor uptake of the GRPr antagonist (64)C...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieser, Gesche, Mansi, Rosalba, Grosu, Anca L., Schultze-Seemann, Wolfgang, Dumont-Walter, Rebecca A., Meyer, Philipp T., Maecke, Helmut R., Reubi, Jean Claude, Weber, Wolfgang A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Short Research Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936293/
https://www.ncbi.nlm.nih.gov/pubmed/24578724
http://dx.doi.org/10.7150/thno.7324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936293/
https://www.ncbi.nlm.nih.gov/pubmed/24578724
http://dx.doi.org/10.7150/thno.7324

Ejemplares similares